Accueil・Liste d'Actions・Zentalis Pharmaceuticals Inc

Zentalis Pharmaceuticals Inc

Fermé

4.87 2.31

Acheter Vendre

Résumé

Variation du prix de l'action

24h

Actuel

Min

4.49

Max

4.83

Chiffres clés
By Trading Economics
Revenu	-136K -35M
BPA	-0.503
Employés	106
EBITDA	2.2M -35M

Recommandations
By TipRanks
Recommandations	Achat
Prévisions sur 12 Mois	+46.44% upside

Dividendes
By Acuity
Prochains Résultats	4 août 2026

Statistiques du Marché
By TradingEconomics
Capitalisation Boursière	41M 336M
Ouverture précédente	2.56
Clôture précédente	4.87

Zentalis Pharmaceuticals Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

7 juil. 2026, 23:56 UTC

Macro News

ETF Constituents

Correlated Moves

Social Media

Financial Select Sector SPDR Fund declines in after-market trading amid escalating Middle East tensions and concerns over oil supply routes affecting inflation and Fed policy.

7 juil. 2026, 23:56 UTC

Correlated Moves

NXP Semiconductors NV shares are lower in after-market hours, following a decline in the Nasdaq 100 Index and amid ongoing geopolitical tensions.

7 juil. 2026, 23:56 UTC

ETF Constituents

The iShares China Large-Cap ETF showed minimal movement in after-market hours, reflecting broader market trends amid concerns over valuations and geopolitical tensions.

7 juil. 2026, 23:56 UTC

Macro News

ETF Constituents

Correlated Moves

ROBO shares advanced in after-market hours, supported by gains from top holdings IPGP and ISRG amid rising crude oil prices and geopolitical tensions.

7 juil. 2026, 23:56 UTC

Macro News

Correlated Moves

The US 30Y Treasury Bond Index is trading lower amid heightened geopolitical tensions following U.S. military strikes against Iran and rising crude oil prices.

7 juil. 2026, 23:56 UTC

Macro News

ETF Constituents

Health Care Select Sector SPDR Fund trades higher after-market, supported by gains in LLY, MDT, and JNJ, despite rising crude oil prices and broader market pressures.

7 juil. 2026, 23:52 UTC

Global equity markets decline amid rising geopolitical tensions, tech stock pullbacks, and widening U.S. trade deficit.

7 juil. 2026, 23:52 UTC

Asia equity markets mixed as Nikkei and Hang Seng decline amid AI boom concerns and geopolitical tensions, while U.S. Treasury yields rise on increased volatility.

7 juil. 2026, 23:52 UTC

European equity markets show mixed results amid geopolitical tensions, with Germany's DAX down 1.3% despite stronger industrial production, while France's trade deficit widens and the euro weakens against the dollar.

7 juil. 2026, 23:52 UTC

U.S. equity indices decline amid widening trade deficit and geopolitical tensions, with tech stocks particularly affected.

7 juil. 2026, 23:51 UTC

Correlated Moves

The SGD/CHF has advanced during Tuesday's session, reflecting a steady increase since Monday's close, supported by a rise in USD/CHF.

7 juil. 2026, 23:51 UTC

Social Media

Correlated Moves

Intuit Inc. shares fell in after-market trading, mirroring a decline in the Nasdaq 100 Index. The stock's price-to-earnings ratio is 17 times earnings.

7 juil. 2026, 23:51 UTC

Microchip Technology Inc shares are higher in after-market hours, reflecting a modest gain since Tuesday's close amid routine trading activity.

7 juil. 2026, 23:51 UTC

Brazil's Central Bank to announce interest rate decision on July 13, 2026, amid cautious sentiment over inflation and economic growth.

7 juil. 2026, 23:51 UTC

Japan's Machinery Orders Data Release on July 14 Expected to Reflect Recovery Amid Mixed Economic Sentiment and Rising Household Spending.

7 juil. 2026, 23:51 UTC

News

Netflix is reportedly bidding for FIFA World Cup U.S. rights valued at $2 billion, boosting positive sentiment as shares rise in after-market trading.

7 juil. 2026, 23:51 UTC

American Airlines Group shares declined in after-market trading, continuing a trend of lower daily closes amid a widening U.S. trade deficit.

7 juil. 2026, 23:51 UTC

Correlated Moves

The USD/CZK is higher today, reflecting a modest increase since Monday's close, amid broader gains in correlated assets like the USD/CHF.

7 juil. 2026, 23:51 UTC

JD.Com Inc shares are trading higher in after-market hours, though no specific news has been identified to explain the movement.

7 juil. 2026, 23:51 UTC

Correlated Moves

Lam Research Corp shares are lower in after-market trading amid a broader market downturn and ongoing geopolitical tensions. The stock has declined for four consecutive sessions.

7 juil. 2026, 23:51 UTC

Correlated Moves

KLA Corp shares are lower in after-market trading, influenced by a widening U.S. trade deficit of $77.6 billion and rising interest rate concerns.

7 juil. 2026, 23:51 UTC

Correlated Moves

Applied Materials Inc shares are lower in after-market hours, reflecting broader market declines and ongoing economic concerns, including a widening U.S. trade deficit.

7 juil. 2026, 23:51 UTC

Social Media

Correlated Moves

Western Digital Corp shares declined in after-market trading, reflecting broader market trends as the Nasdaq 100 Index also fell. The asset remains below its 20-day moving average.

7 juil. 2026, 23:46 UTC

eBay Inc shares are lower in after-market hours amid no specific news. The U.S. trade deficit widened in May, impacting market sentiment.

7 juil. 2026, 23:46 UTC

Macro News

ETF Constituents

Crude oil prices rose amid U.S.-Iran tensions, potentially impacting biotechnology costs. iShares Biotechnology ETF traded near unchanged during after-market hours.

7 juil. 2026, 23:46 UTC

Macro News

ETF Constituents

COPX is higher in after-market hours, supported by strong performances from Freeport-McMoRan and Southern Copper amid rising crude oil prices and geopolitical tensions.

7 juil. 2026, 23:46 UTC

Trip.com Group Ltd shares declined in after-market trading, pulling back from a session high and remaining below their 20-day moving average.

7 juil. 2026, 23:46 UTC

Lululemon Athletica Inc shares are lower in after-market hours amid broader concerns over the U.S. trade deficit, which widened to $77.6 billion in May.

7 juil. 2026, 23:46 UTC

Terra is trading higher during Tuesday's session, despite pulling back from earlier highs. It remains above its 20-day moving average.

7 juil. 2026, 23:46 UTC

ETF Constituents

Macro News

Correlated Moves

The iShares MSCI South Korea ETF is lower in after-market hours, influenced by rising crude oil prices and declines in major indices.

Comparaison

Variation de prix

Zentalis Pharmaceuticals Inc prévision

Objectif de Prix

By TipRanks

46.44% hausse

Prévisions sur 12 Mois

Moyen 7 USD 46.44%

Haut 10 USD

Bas 4 USD

Basé sur 7 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat

7 ratings

Achat

Maintien

Vente

Basé sur 7 qui ont noté l'action Microsoft Corp. au cours des 3 derniers mois.

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

À Propos Zentalis Pharmaceuticals Inc

Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers. Its products candidatures include the ZN-c3, an inhibitor of WEE1, a protein tyrosine kinase for the treatment of inhibitor for advanced solid tumors and hematological malignancies; in Phase 2 clinical trial as a monotherapy for the treatment of uterine serous carcinoma indications; Phase 2 clinical trial in Cyclin E1 driven high-grade serous ovarian cancer, fallopian tube, or primary peritoneal cancer; Phase 1/2 clinical trial in combination with PARPi for platinum-resistant ovarian cancer; Phase 1b clinical trial in combination with chemotherapy in platinum-resistant ovarian, and peritoneal or fallopian tube cancer; Phase 1/2 clinical trial in combination with chemotherapy in relapsed or refractory osteosarcoma; Phase 1/2 clinical trial with encorafenib and cetuximab for mutant metastatic colorectal cancer; and Phase 1/2 clinical trial in combination with chemotherapy in pancreatic cancer. The company's products pipeline also includes ZN-d5, an oral small molecule inhibitor of B-cell lymphoma 2, for hematological malignancies and related disorders; and BCL-xL heterobifunctional degrader, a member of the anti-apoptotic BCL-2 proteins, for solid tumors and hematological malignancies. Zentalis Pharmaceuticals, Inc. has licensing agreements and strategic collaborations with Recurium IP Holdings, LLC; Pfizer, Inc.; Zentera Therapeutics; Dana-Farber; and GlaxoSmithKline plc. The company was incorporated in 2014 and is headquartered in New York, New York.